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Abstract

In this study a simple method using standard flood-field corrected Electronic Portal Imaging Device (EPID)
images for routine Intensity Modulated Radiation Therapy (IMRT) Quality Assurance (QA) was investigated.
The EPID QA system was designed and tested on a Siemens Oncor Impression linear accelerator with an
OptiVue 1000ST EPID panel (Siemens Medical Solutions USA, Inc, USA) and an Elekta Axesse linear
accelerator with an iViewGT EPID (Elekta AB, Sweden) for 6 and 10 MV IMRT fields with Step-and-Shoot
and dynamic-MLC delivery. Two different planning systems were used for patient IMRT field generation for
comparison with the measured EPID fluences. All measured IMRT plans had >95% agreement to the
planning fluences (using 3 cGy / 3 mm Gamma Criteria) and were comparable to the pass-rates calculated
using a 2-D diode array dosimeter.
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Abstract. In this study a simple method using standard flood-field corrected Electronic Portal
Imaging Device (EPID) images for routine Intensity Modulated Radiation Therapy (IMRT)
Quality Assurance (QA) was investigated. The EPID QA system was designed and tested on a
Siemens Oncor Impression linear accelerator with an OptiVue 1000ST EPID panel (Siemens
Medical Solutions USA, Inc, USA) and an Elekta Axesse linear accelerator with an iViewGT
EPID (Elekta AB, Sweden) for 6 and 10 MV IMRT fields with Step-and-Shoot and dynamicMLC delivery. Two different planning systems were used for patient IMRT field generation
for comparison with the measured EPID fluences. All measured IMRT plans had >95%
agreement to the planning fluences (using 3 cGy / 3 mm Gamma Criteria) and were
comparable to the pass-rates calculated using a 2-D diode array dosimeter.

1. Introduction
Intensity Modulated Radiation Therapy (IMRT) is used routinely for prostate, head and neck, and
abdominal treatment sites at the Prince of Wales Hospital (POWH). Per-patient pre-treatment QA on
treatment fields is recommended in ESTRO Booklet 9 [1], ICRU Report 83 [2] and the ASTRO
practice guideline for IMRT [3]. All IMRT treatments at the POWH have QA performed with the
MapCHECK (Sun Nuclear Corporation, Fl, USA) two-dimensional diode array dosimeter for a perfield comparison with treatment planning system (TPS) planar dose fluences. The comparison method
used is Gamma Analysis with 3 cGy / 3 mm criteria, with greater than 95% of the dose points being in
the criteria. Ongoing increases in IMRT patient workload puts pressure on physics resources and has
led to investigations for alternatives to the standard diode array based method.
Amorphous silicon (a-Si) Electronic Portal Imaging Devices (EPIDs) have been implemented for
two-dimensional dosimetry in many departments globally. EPIDs have many characteristics that make
them well suited for IMRT dosimetry [4-8] and the reduced equipment set-up time compared to other
dosimeters has the potential to improve efficiencies. Many approaches have been implemented for
portal dosimetry as described in a review paper by Van Elmpt [9]. Despite numerous research papers
on the topic, and several commercial products being available, portal dosimetry is not yet widespread
across all vendor equipment.
Content from this work may be used under the terms of the Creative Commons Attribution 3.0 licence. Any further distribution
of this work must maintain attribution to the author(s) and the title of the work, journal citation and DOI.
Published under licence by IOP Publishing Ltd
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Lee [10] implemented a simplified model for Varian EPID dosimetry that calculated a reference
depth in water (dref) at which the EPID response matched conventional dosimeters. The EPID dose
response was matched to dose in water at dref based on field size factors and profile shape. This method
eliminates the need for complex scatter corrections and EPID modeling and makes use of an existing
TPS to predict EPID response, providing a simple QA tool for IMRT available to any department.
This method has not yet been implemented on non-Varian equipment. In this work we implement a
similar model across a variety of planning and delivery platforms available at POWH.
2. Materials and Methods
2.1. EPID image acquisition
EPID images were acquired using non-transit methods (no object in the path of the beam), with the
panel set at an SSD of 145 cm for the Siemens OptiVue1000ST and 160 cm for the Elekta iViewGT.
Based on preliminary measurements a 1 cm solid-water plate was required on the EPID panel for 10
MV measurements to allow sufficient build-up for electronic equilibrium in the detector. No build-up
was required for 6 MV measurements.
Images were exported as frame-averaged images in DICOM format for the Siemens OptiVue
1000ST, and lossless JPEG format for the Elekta iViewGT. Image analysis software was used for
conversion of frame-averaged images to integrated images and for analysis of measured EPID fields.
2.2. EPID Calibration
Methods for determining the reference depth in water (dref) were adapted from the work by Lee [11]
for Siemens and Elekta EPID images. One difference in the method we used to that of Lee et al. is
that we did not implement a profile correction. In our method the FF corrected images were used as
acquired. Details of determining dref will be reported elsewhere.
Pixel values for a measured field must be converted to absorbed dose using a measured pixel-todose calibration factor (CFEPID:Dose(x,y)) for EPID dosimetry. The calibration factor was calculated for
6 and 10 MV based on measurements with the EPID and the absorbed dose in water at dref for a 10 x
10 cm2 field. The CFEPID:Dose(x,y) was calculated by dividing the absorbed dose at dref (Dosedref) by the
average EPID pixel value (in a 0.4 x 0.4 cm region) at the beam central axis (Pixel (x,y)).

CFEPID:Dose ( x, y ) =

Dosed ref (cGy)
Pixel ( x, y )

(1)

EPID calibration factors were subsequently applied to all measured images for conversion of pixel
values to dose (cGy).
2.3. IMRT Fluence map generation
Dose fluences were generated for each IMRT patient field using XiO v4.64 and Monaco v3.1 planning
systems (Elekta AB, Stockholm, Sweden). XiO uses a superposition algorithm for dose computation
whereas Monaco dose calculation is based on a Monte Carlo algorithm.
QA fields were created by transferring the patient plan to a virtual water phantom with dimensions
40 x 40 x 40 cm on XiO, and onto a CT scan of a solid water phantom with dimensions of 30 x 30 x
30 cm for Monaco (due to software restrictions, Monaco cannot calculate dose on a virtual phantom).
Gantry, Collimator and Couch angles were set to zero degrees (0°) planar dose corresponding to dref
for EPID QA beams and at a depth of 3.0 cm for MapCHECK QA beams. Beams were exported at
these depths for EPID and MapCHECK plans respectively.
2.4. IMRT Analysis
IMRT field-by-field comparisons were performed using Gamma Analysis with clinical criteria of 3
cGy / 3 mm, and a 10% low dose threshold. A minimum of 95% of points passing the criteria was a
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requirement for plan approval. The IMRT suite in RIT v5.3 (Radiological Imaging Technology,
Colorado Springs, USA) was used for Elekta iViewGT Gamma Analysis. OmniPro I’mRT (IBA
Dosimetry GmbH, Schwarzenbruck, Germany) is a pre-treatment verification system for IMRT and
rotational therapies and was used for Siemens OptiVue 1000ST Gamma analysis. Different programs
were used for IMRT comparisons due to compatibility issues with the different vendor image formats.
3. Clinical Results
IMRT QA fields for each patient were measured with the EPID and the MapCHECK diode array and
compared to TPS-generated fluence maps at calculation depths stated in Section 2.4. The percentage
pass rate presented in this paper is an average Gamma Analysis result for all treatment fields in an
individual patient plan.
EPID vendor-type, beam energy, and the percentage of pixels passing the Gamma criteria of 3 cGy
/ 3mm with EPID and MapCHECK systems is presented in table 2 for 6 and 10 MV IMRT fields.
Note that 10 MV fields were measured with the OptiVue 1000ST only as the iViewGT cannot
currently acquire 10 MV images. The delivery method for all listed patients was Step-and-Shoot, with
the exception of Patient 9 having a dynamic MLC delivery.
Table 2: Gamma Analysis results for EPID and MapCHECK IMRT QA.
Percentage pixels Passing
Gamma Analysis Per Plan (%)
Patient
1
2
3
4
5
6
7
8
9
10
11
12
13

Treatment Site
Hypopharynx
Head & Neck
Base of Tongue
Head & Neck
Tonsil
Nasopharynx
SCC
Head & Neck
Head & Neck
Sacrum
Prostate Bed
Anus
Anus

Energy
(MV)
6
6
6
6
6
6
6
6
6
6
10
10
10

Machine
Siemens
Siemens
Siemens
Siemens
Siemens
Siemens
Siemens
Elekta
Elekta
Elekta
Siemens
Siemens
Siemens

EPID
99.3
98.5
98.6
99.4
99.4
97.5
97.4
97.8
97.2
95.5
96.5
97.6
96.6

MapCHECK
98.4
100.0
99.3
98.5
99.2
99.1
98.8
99.0
99.6
98.2
97.2
99.5
96.9

Gamma Analysis results for IMRT QA fields measured with the EPID were compared to Gamma
analysis results for fields measured with the MapCHECK. Pass rates for the EPID were comparable to
the MapCHECK using clinical criteria of 3 cGy / 3mm. All EPID results for the total treatment were
within a maximum of ±2.4% from the MapCHECK gamma analysis results. The average percentage
of pixels in a treatment plan complying with gamma criteria was over 95% in all cases tested.
2 out of 86 EPID and 3 out of 86 MapCHECK measured beams failed the 95% pass rate. One of
these beams did not pass either measurement method.
4. Discussion and Conclusion
A simple EPID dosimetry procedure was implemented and tested for clinical IMRT fields using a
variety of common equipment and techniques, including both Step and Shoot and dynamic-MLC
delivery techniques, Siemens and Elekta linear accelerators with a-Si EPIDs, Xio and Monaco
treatment planning systems, and 6 MV and 10 MV energies.
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Using a Gamma Criteria of 3 cGy / 3mm for IMRT field comparison, all patient plans had an
average Gamma pass rate above 95%. EPID results agreed with the MapCHECK diode array with an
average difference of 0.7% and a maximum difference of 2.4% in gamma pass rates.
Results from this study indicate that the EPID IMRT QA procedure can be used as an accurate and
reliable tool for per-patient pre-treatment QA across different platforms and delivery techniques.
Further assessment is required to determine the procedure efficiency compared to the current standard
method, and to implement the system across multiple-departments with a still wider range of vendor
equipment.
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